期刊文献+

人乳头瘤病毒感染与宫颈癌的研究进展 被引量:10

Progress in research on relationship between human papillomavirus infection and cervical carcinma
在线阅读 下载PDF
导出
摘要 宫颈癌是女性常见的恶性肿瘤,仅次于乳腺癌,人乳头瘤病毒感染是其形成过程中的重要条件,但大多数感染人乳头瘤病毒的妇女可自行缓解,仅少数妇女持续感染并发展为宫颈上皮内瘤变、宫颈癌,说明宫颈癌的发生过程中还存在其他的协同因素。宫颈癌的治疗方法近年来无重大突破,因此,重点在于癌前病变的筛查及预防。目前人乳头瘤病毒疫苗的问世为宫颈癌的防治带来了希望,已经成为一个研究热点。该文就人乳头瘤病毒感染与宫颈癌的发生关系及人乳头瘤病毒疫苗的研究进展作了系统的回顾。 Cervical carcinoma,which its incidence rate is next to that of breast cancer,is one of the most common malignant tumors of the females.One of its important development conditions is HPV infection.Most HPV infected women can completely relief by herself,and only a minority of HPV infected women develop CIN or cervical carcinoma,suggesting that in addition to HPV infection there are other cofactors to induce development of cervical carcinoma.For recent years,there are no great breakthroughs in treatment of cervical carcinoma,so the research mainly focuses on screening and prevention of precancerous lesions of the disease.At present,emergence of HPV vaccine brings hopes for prevention and treatment of cervical carcinoma and it has become a hot-spot of the research.This paper reviewed progress in research on relationship between HPV infection and development of cervical carcinoma and development of HPV vaccine.
出处 《中国妇幼健康研究》 2007年第5期436-440,共5页 Chinese Journal of Woman and Child Health Research
关键词 人乳头瘤病毒感染 宫颈癌 预防 人乳头瘤病毒疫苗 human papilloma virus infection cervical carcinoma prevention HPV vaccine
  • 相关文献

参考文献28

  • 1[1]Chen Z,Terai M,Fu L,et al.Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses[J].J Virol,2005,79(11):7014-7023.
  • 2[2]Jungw W,ChunL S D.Strategies against human papillomavlms infection and cervical cancer[J].Microbiol,2004,42(4):255-266.
  • 3[3]Munoz N,Bosch F X,De Sanjose S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer[J].N Engl J Med,2003,348:518-527.
  • 4[4]Franceschi S.The LARC commitment to cancel-prevention:The exanlpie of papillomavirus and cervical cancer[J].Recent Results Cancer Res,2005,166:277-297.
  • 5[5]Ahekruse S F,Laeey J V J,Brinton I A,et al.Comparison of human papillomavirus genotype sexual,and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma[J].Am J Obstet Gynecol,2003,188(3):657-663.
  • 6[6]Banuelos A,Reyes E,Ocadiz R,et al.Neocarzinostatin induces an effective p53-dependent response in human papillomavirus positive cervical cancer cells[J].J Pharmacol Exp Ther,2003,306(2):671-680.
  • 7[7]Neville F H,Jonathan S B,Barbara L A,et al.Paractical gynecologic oncology[M].4/E,United States:Arrangement with Lippincort Williams and Wilkins,2005.215-224.
  • 8[8]Wang L P.Progress in research and countermeasures on relationship between papillomavirus infection and cervical carcinma[J].J Diag Pathol,2007,14(2):86-89.
  • 9[9]Sandri M T,Lentati P,Benini E,et al.Comparison of the digene HC2 assay and the roche amplicor human papillomavirus (HPV) test for detection of high2risk HPV genotypes in cervical samples[J].J Clin Microbiol,2006,44(6):2141-2146.
  • 10[10]De Villiers E M.Relationship between steroid hormone contraceptives and HPV,cervical intraepithelial neoplasia and cervical carcinoma[J].Int J Cancer,2003,103(6):705-708.

同被引文献121

引证文献10

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部